Role of glucocorticoids on inflammatory response in nonimmunosuppressed patients with pneumonia: a pilot study - PubMed (original) (raw)
Clinical Trial
Role of glucocorticoids on inflammatory response in nonimmunosuppressed patients with pneumonia: a pilot study
C Montón et al. Eur Respir J. 1999 Jul.
Free article
Abstract
The aim of the study was to assess the potential role of glucocorticoids (GC) in modulating systemic and pulmonary inflammatory responses in mechanically ventilated patients with severe pneumonia. Twenty mechanically ventilated patients with pneumonia treated at a respiratory intensive care unit (RICU) of a 1,000-bed teaching hospital were prospectively studied. All patients had received prior antimicrobial treatment. Eleven patients received GC (mean+/-SD dose of i.v. methylprednisolone 677+/-508 mg for 9+/-7 days), mainly for bronchial dilatation. Serum and bronchoalveolar lavage fluid (BALF) tumour necrosis factor (TNF)-alpha, interleukin (IL)-1beta, IL-6 and C-reactive protein levels were measured in all patients. The inflammatory response was attenuated in patients receiving GC, both systemically (IL-6 1,089+/-342 versus 630+/-385 pg x mL(-1), p=0.03; C-reactive protein 34+/-5 versus 19+/-5 mg x L(-1), p=0.04) and locally in BALF (TNF-alpha 118+/-50 versus 24+/-5 pg x mL(-1), p= 0.05; neutrophil count: 2.4+/-1.1 x 10(9) cells x L(-1) (93+/-3%) versus 1.9+/-1.8 x 10(9) cells x L(-1) (57+/-16%), p=0.03). Four of the 11 (36%) patients receiving GC died compared to six (67%) who were not receiving GC (p=0.37). The present pilot study suggests that glucocorticoids decrease systemic and lung inflammatory responses in mechanically ventilated patients with severe pneumonia receiving antimicrobial treatment.
Similar articles
- Cytokine expression in severe pneumonia: a bronchoalveolar lavage study.
Montón C, Torres A, El-Ebiary M, Filella X, Xaubet A, de la Bellacasa JP. Montón C, et al. Crit Care Med. 1999 Sep;27(9):1745-53. doi: 10.1097/00003246-199909000-00008. Crit Care Med. 1999. PMID: 10507593 - Bronchoalveolar interleukin-1 beta: a marker of bacterial burden in mechanically ventilated patients with community-acquired pneumonia.
Wu CL, Lee YL, Chang KM, Chang GC, King SL, Chiang CD, Niederman MS. Wu CL, et al. Crit Care Med. 2003 Mar;31(3):812-7. doi: 10.1097/01.CCM.0000054865.47068.58. Crit Care Med. 2003. PMID: 12626989 - Compartmentalisation of cytokines and cytokine inhibitors in ventilator-associated pneumonia.
Millo JL, Schultz MJ, Williams C, Weverling GJ, Ringrose T, Mackinlay CI, van der Poll T, Garrard CS. Millo JL, et al. Intensive Care Med. 2004 Jan;30(1):68-74. doi: 10.1007/s00134-003-2060-0. Epub 2003 Nov 21. Intensive Care Med. 2004. PMID: 14634726 - Production of inflammatory cytokines in ventilator-induced lung injury: a reappraisal.
Ricard JD, Dreyfuss D, Saumon G. Ricard JD, et al. Am J Respir Crit Care Med. 2001 Apr;163(5):1176-80. doi: 10.1164/ajrccm.163.5.2006053. Am J Respir Crit Care Med. 2001. PMID: 11316656 - Lung inflammatory response in pneumonia.
Montón C, Torres A. Montón C, et al. Monaldi Arch Chest Dis. 1998 Feb;53(1):56-63. Monaldi Arch Chest Dis. 1998. PMID: 9632909 Review.
Cited by
- Impact of different corticosteroids on severe community-acquired pneumonia: a systematic review and meta-analysis.
See XY, Wang TH, Chang YC, Lo J, Liu W, Choo CYW, Lee YC, Ma KSK, Chiang CH, Hsia YP, Chiang CH, Chiang CH. See XY, et al. BMJ Open Respir Res. 2024 Jan 22;11(1):e002141. doi: 10.1136/bmjresp-2023-002141. BMJ Open Respir Res. 2024. PMID: 38262670 Free PMC article. - Effect of 2 Different High-Dose Methylprednisolone Treatments on Clinical Outcomes in Severe COVID-19 Patients.
Eser F, Kayaaslan B, Kaya Kalem A, Hasanoğlu İ, Bilgiç Z, Asiltürk D, Kaplan B, Güner R. Eser F, et al. Thorac Res Pract. 2023 Mar;24(2):66-75. doi: 10.5152/ThoracResPract.2023.22050. Thorac Res Pract. 2023. PMID: 37503642 Free PMC article. - The Intersection of COVID-19 and Rheumatoid Arthritis: Shared Mechanisms, Treatment Challenges, and Potential Therapeutic Approaches.
Xiao J, Liang C, Zhang L, Li J, Liu S. Xiao J, et al. Aging Dis. 2023 Aug 1;14(4):1196-1213. doi: 10.14336/AD.2023.0406. Aging Dis. 2023. PMID: 37163438 Free PMC article. Review. - An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19).
Alagheband Bahrami A, Azargoonjahromi A, Sadraei S, Aarabi A, Payandeh Z, Rajabibazl M. Alagheband Bahrami A, et al. Cell Mol Biol Lett. 2022 May 13;27(1):38. doi: 10.1186/s11658-022-00339-3. Cell Mol Biol Lett. 2022. PMID: 35562685 Free PMC article. Review. - Nitric-Oxide-Releasing Dexamethasone Derivative NCX-1005 Improves Lung Function and Attenuates Inflammation in Experimental Lavage-Induced ARDS.
Kosutova P, Kolomaznik M, Calkovska A, Mokra D, Mikolka P. Kosutova P, et al. Pharmaceutics. 2021 Dec 5;13(12):2092. doi: 10.3390/pharmaceutics13122092. Pharmaceutics. 2021. PMID: 34959373 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous